Previous Article | Next Article 
Infection and Immunity, April 2000, p. 2142-2147, Vol. 68, No. 4
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Innate Lung Defenses and Compromised Pseudomonas
aeruginosa Clearance in the Malnourished Mouse Model of
Respiratory Infections in Cystic Fibrosis
H.
Yu,1
S.
Z.
Nasr,2 and
V.
Deretic1,*
Departments of Microbiology and
Immunology1 and
Pediatrics,2 University of Michigan
Medical School, Ann Arbor, Michigan
Received 28 September 1999/Returned for modification 22 November
1999/Accepted 3 January 2000
 |
ABSTRACT |
Cystic fibrosis (CF) is characterized by dysfunction of the
digestive and respiratory tracts resulting in generalized malnutrition and chronic respiratory infections. Chronic lung infections with Pseudomonas aeruginosa, intense neutrophil-dominated airway
inflammation, and progressive lung disease are the major cause of high
morbidity and mortality in CF. Here we investigated the effects of
malnutrition in CF on innate lung defenses, susceptibility to P. aeruginosa colonization, and associated inflammation, using
aerosol models of acute and chronic infections in normal, malnourished,
and transgenic mice. CFTRm1Unc
/
knockout
mice displayed body weight variations and showed variable pulmonary
clearance of P. aeruginosa. This variability was not detected in bitransgenic
CFTRm1Unc
/
(FABP-hCFTR) mice in which the
intestinal defect had been corrected. Diet-induced protein calorie
malnutrition in C57BL/6J mice resulted in impaired pulmonary clearance
of P. aeruginosa. Tumor necrosis factor alpha (TNF-
) and
nitrite levels detected upon exposure to P. aeruginosa
aerosols were lower in the lungs of the malnourished C57BL/6J mice
relative than in lungs of mice fed a normal diet. The role of TNF-
and reactive nitrogen intermediates in P. aeruginosa clearance was tested in TNF-
and inducible nitric oxide synthase (iNOS) knockout mice. P. aeruginosa clearance was
diminished in transgenic TNF-
- and iNOS-deficient mice. In contrast
to the effects of TNF-
and iNOS, gamma interferon knockout
mice retained a full capacity to eliminate P. aeruginosa
from the lung. Malnutrition also contributed to excessive
inflammation in C57BL/6J mice upon chronic challenge with P. aeruginosa. The repeatedly infected malnourished host did not
produce interleukin-10, a major anti-inflammatory cytokine absent or
diminished in the bronchoalveolar fluids of CF patients. These results
are consistent with a model in which defective CFTR in the
intestinal tract leads to nutritional deficiency which in turn
contributes to compromised innate lung defenses, bacterial
colonization, and excessive inflammation in the CF respiratory tract.
 |
INTRODUCTION |
Cystic fibrosis (CF), the most
common inheritable lethal disease among Caucasians, is caused by
mutations in the CFTR gene encoding a chloride channel (CF
transmembrane conductance regulator [CFTR]) (10). CF is
characterized by chronic obstructive pulmonary disease, intestinal
problems, and generalized malnutrition (30). As the disease
progresses, the lungs of CF patients become infected and colonized with
a variety of pathogens. Among these, Pseudomonas aeruginosa
represents the predominant CF pathogen (15). Persistent pulmonary infections with P. aeruginosa, intense
neutrophil-dominated airway inflammation, and progressive lung disease
are presently the major cause of high morbidity and mortality in CF
(23).
Several concurrent proposals have been put forward to explain the
relationship between the defect in CFTR and predilection for
P. aeruginosa infections (4, 5, 12, 22, 31, 36, 40). The altered electrolyte composition of CF epithelial
secretions has been linked to reduced bactericidal properties of
defensins (12, 36). CFTR has also been implicated in
P. aeruginosa uptake by respiratory epithelial cells
(31). Reduced sialylation of glycoconjugates on the surface
of epithelial cells in CF has been associated with increased P. aeruginosa adhesion (40). Other studies focusing on
cytokine profiles in bronchoalveolar lavage fluids of CF patients have
suggested that the excessive inflammation in the CF lung may be
attributed to endogenously increased levels of proinflammatory
cytokines such as tumor necrosis factor alpha (TNF-
) and interleukin
(IL-8) (5, 22). Considering the multitude of sometimes
conflicting models, factors rendering the CF lung prone to infections
are still not conclusively defined.
Chronic malnutrition with progressive weight loss has been recognized
as a problem in CF (30). Almost 50% of newly diagnosed CF
infants suffer from various degrees of malnutrition (25), maldigestion, and malabsorption (21, 28). About 85% of CF patients show pancreatic insufficiency and severe steatorrhoea due to
the problems with their digestive systems (30).
Approximately 16% of CF newborns and adults also present with meconium
ileus or meconium ileus equivalent, one of the most common causes of intestinal obstruction in CF (7, 11). CF patients have
increased energy expenditure and energy deficit and are underweight.
The combined effects of malabsorption and anorexia in CF result in inefficient utilization of proteins, lipids, vitamins, and trace elements. Significant growth retardation with weight loss has been seen
in all age groups of CF patients (30). The issues related to
protein energy malnutrition (PEM) in CF are of particular significance
due to their import on long-term prognosis in this disease
(24).
Here we tested whether some aspects of P. aeruginosa
infections in CF could be explained by effects of malnutrition on
relevant innate defenses of the respiratory system. We used an aerosol infection model in combination with several strains of transgenic mice
and normal mice subjected to PEM (which represents one aspect of
nutritional problems in CF) to model the role of innate defenses in
P. aeruginosa pulmonary clearance. We report the roles of
malnutrition, relevant proinflammatory and anti-inflammatory cytokines,
and other mediators of innate lung immunity in P. aeruginosa
clearance from the respiratory tract.
 |
MATERIALS AND METHODS |
Bacterial strains and growth conditions.
For nebulization,
P. aeruginosa PAO1 was grown in 200 ml of Luria broth at
37°C for 12 h and harvested by centrifugation at 4,000 rpm for
15 min at 4°C. Pellets (1.2 g [wet cell mass]) were washed once in
cold 1% Proteose Peptone (Difco) phosphate-buffered saline (pH 7.4)
and resuspended in cold phosphate-buffered saline. The suspension was
adjusted to 1011 CFU/ml, and 5 ml was used for nebulization
as previously described (39).
Animals.
Mice were 8 weeks old at the inception of single-
or repeated-aerosol-exposure experiments as previously described
(39). All animals were housed under specific-pathogen-free
conditions. C57BL/6J and transgenic mice (four per group) were from The
Jackson Laboratory (Bar Harbor, Maine). Gamma interferon (IFN-
)
knockout mice were C57BL/6-Ifn
tm1Ts (JR2287); inducible
nitric oxide synthase 2 (iNOS-2) knockout mice were
C57BL/6-Nos2tmlLau (JR2609). CFTR transgenic
animals were CFTRm1UNC
/
homozygotes
(37) obtained by breeding heterozygous
CFTRm1UNC+/
mice purchased from The Jackson
Laboratory and genotyping mice following instructions from the
supplier. CFTRm1Unc
/
(FABP-hCFTR) mice were
purchased from The Jackson Laboratory and breeding colony maintained
without further typing.
CFTRm1Unc
/
(FABP-hCFTR) mice have their
intestinal defect corrected by the presence of a functional human
CFTR gene expressed from a rat intestinal fatty acid-binding
protein gene promoter (41).
Infection model.
The aerosol infection model and equipment
(Glas-Col, Terre Haute, Ind.) were as previously described
(39). For single-exposure experiments, animals were
sacrificed 18 h upon exposure to P. aeruginosa
aerosols. For chronic infection model (39), animals were
repeatedly subjected to P. aeruginosa aerosols every 72 h (eight times over a period of 22 days) and sacrificed 18 h
following the last exposure. Bacteriological analysis and
histopathology workup were as previously described (39).
Relative bacterial survival represents the percent of CFU remaining in
the lungs compared to the initially deposited CFU in the lungs
determined by sacrificing a group of animals immediately following the
aerosol exposure (39).
Generation of PEM in mice.
A standard protocol was followed
(38). Low (2%)- and full (20%)-protein and protein-free
diets were from BIOSERV (Frenchtown, N.J.). These diets were made
isocaloric to the basic diet (casein-based mouse diet) by carbohydrate
supplement. The protein-free diet consisted of 7% fat, 5% fiber, 3%
ash, and 79% carbohydrate. Compositions of low- and normal-protein
diets, respectively, were as follows: protein (2 and 20%), fat (7 and
7%), fiber (5 and 5%), ash (3 and 3%), and carbohydrate (77 and
57%). The protein component in these diets was hydrolyzed casein. The
caloric content of the diet was 3.6 kcal/g. An adult mouse usually
consumes about 3 g/day (10.8 kcal). Analysis of protein, fat, and
carbohydrate content of diets was performed for quality control. After
3 weeks on protein-free diet, during which animals typically lose about
50% of their body weight (38), mice were placed on
low-protein or normal-protein diet. The time of infection following the
introduction of low (PEM)- or normal (control)-protein diets was 2 weeks or after switching from low- to normal-protein diet for
additional 2 weeks (PEM-recovered [PEM-R] animals). In
single-aerosol-exposure experiments, PEM animals had body weights of
10.7 ± 1.2 g (n = 4); control mice on the
normal diet weighed 19.1 ± 1.3 g (n = 4),
and PEM-R animals had body weights of 20.9 ± 2.1 g
(n = 8). The animals subjected to repeated P. aeruginosa aerosol exposure (chronic infection/inflammation model
[39]) weighed 13.5 ± 0.9 g (n = 5) in the PEM group, versus 19.6 ± 1.1 g (n = 5) in the control group fed normal diet. A sentinel group of
five PEM mice were found free of viral and bacterial infections.
Cytokine levels, MPD activity, and nitrite concentration.
TNF-
, macrophage inflammatory protein 2 (MIP-2), and
chemokine-induced neutrophil chemoattractant KC (KC) were measured in lung tissue (left lung lobe homogenates), using enzyme-linked immunosorbent assay kits (R&D Systems, Minneapolis, Minn.) according to
the manufacturer's instructions. Detection limits for murine TNF-
,
MIP-2, and KC were 5.0, 1.5, and 2.0 pg/ml, respectively. Myeloperoxidase (MPD) in the lung tissues was measured as described by
Hobden et al. (17) after dilution 1:1 with
cetyltrimethylammonium bromide (0.75%, final concentration; United
States Biochemical). Samples were freeze-thawed three times and
sonicated once before centrifugation at 14,000 rpm for 10 min at 4°C.
An aliquot of the supernatant was mixed with 2.9 ml of 50 mM potassium
phosphate buffer (pH 6.0) containing o-dianisidine
dihydrochloride (0.53 mM; Sigma) and H2O2 (0.15 mM). One unit of MPO activity is defined as the decomposition of 1 mmol
of peroxide/min at 25°C, representing a change in
A460 of 1.13 × 10
2/min. Lung
homogenates were first centrifuged at 10,000 rpm for 20 min at 4°C
and filtered (0.45 µm-pore-size filter) before nitrate determination.
Total nitrite (nitrite plus nitrate reduced enzymatically to nitrite)
in lung homogenates (expressed in nanomoles per gram of lung tissue)
was determined using a kit from Cayman Chemical (Ann Arbor, Mich.). The
levels of TNF-
and NO in uninfected animals were below detection
limits (TNF-
, 34.0 pg/g of tissue; NO, 14 nmol of nitrite/g of
tissue). The levels of MIP-2 and KC in uninfected animals were 195 ± 15 and 210 ± 14 pg/g of tissue, respectively.
Statistical analysis.
Analysis of variance (ANOVA),
t test, and post hoc analyses were performed with SuperANOVA
(version 1.11; Abacus Concepts) and StatView (version 4.5; Abacus Concepts).
 |
RESULTS |
Respiratory clearance in CFTR transgenic mice with and
without correction of the intestinal defect: effects of
malnutrition.
Using an aerosol infection model (39), we
observed variability among CF knockout mice (37) in the
ability to clear P. aeruginosa (Table
1). The
CFTRm1UNC
/
mice presented with two extremes
of either clearing or not clearing P. aeruginosa, a
phenomenon not encountered with any other strains of age-matched mice
in the mice used. This finding appeared to be associated with
variations in body weight and nutritional status of the mice. In
CFTRm1UNC
/
mice that had their intestinal
defect corrected by the presence of a functional human CFTR
gene expressed from a rat intestinal fatty acid-binding protein gene
promoter CFTRm1Unc
/
(FABP-hCFTR mice)
(41), P. aeruginosa was efficiently cleared from
the lung and the variability was no longer observed (Table 1). One
interpretation of these observations is that repairing the
CFTR defect in the intestinal tract improved lung defenses against P. aeruginosa. Normal C57BL/6J mice in which
PEM was induced showed an 11-fold-reduced capacity to clear
P. aeruginosa (Fig. 1A, PEM).
This defect was promptly restored by placing the malnourished mice on a
normal-protein (20%) diet (Fig. 1A, PEM-R). These results indicate
that malnutrition impairs pulmonary clearance of P. aeruginosa.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Pulmonary clearance of P. aeruginosa in
CFTRm1Unc / mice,
CFTR+/+ littermates, and
CFTRm1Unc / (FABP-hCFTR) bitransgenic mice
with corrected intestinal defecta
|
|

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Pseudomonas clearance from the lungs of
control C57BL/6J mice (normal-protein diet), PEM mice, and PEM-R mice
(as defined in Materials and Methods). P. aeruginosa was
delivered as aerosol (initial deposition was 2 × 106
to 8 × 106 CFU/g of lung tissue). Bacterial survival
was expressed as the fraction of the initially deposited CFU
(determined by sacrificing a group of animals immediately following
exposure) remaining in the lung 18 h following infection (relative
bacterial survival). (B) Pulmonary clearance in transgenic iNOS,
TNF- , and IFN- knockout mice. **, P < 0.01
(ANOVA post hoc t test; relative to control in panel A or
relative to C57BL/6J in panel B).
|
|
Clearance of P. aeruginosa in IFN-
, iNOS, and
TNF-
transgenic mice.
As mutations in CFTR have
severe effects on the digestive system, the resulting nutritional
defect may impair the innate defense systems in the lung. PEM can
selectively compromise the immune system in the lung, with IFN-
,
TNF-
, and iNOS being the major effector mechanisms affected
(9). To test whether and which of these factors play a role
in P. aeruginosa clearance from the lung, we investigated
the roles of IFN-
, iNOS, and TNF-
in corresponding transgenic
mice. Age-matched IFN-
, iNOS, and TNF-
transgenic knockout and
C57BL/6J mice were exposed to P. aeruginosa aerosols. The
strongest effect on P. aeruginosa was observed in TNF-
transgenic mice, which showed a 19-fold decrease in the efficiency of
P. aeruginosa clearance relative to C57BL/6J mice
(P < 0.01). The iNOS knockout animals also showed a
threefold-reduced clearance (P < 0.01), while IFN-
animals displayed no defect in removal of P. aeruginosa from
the lungs (P = 0.786). These results suggest that iNOS
and TNF-
play important roles in the innate resistance to P. aeruginosa and its clearance from the respiratory tract.
Malnutrition affects iNOS and TNF-
output in response to
respiratory infection with P. aeruginosa.
Considering the
significant role of iNOS and TNF-
, we next tested whether NO and
TNF-
elicited by respiratory infection with P. aeruginosa
were affected by malnutrition. TNF-
was reduced 2.8-fold
(P < 0.01) (Fig. 2A) and
NO production (determined by measuring levels of its metabolite
nitrite) was reduced by 58% (P < 0.01) (Fig. 2B) in
C57BL/6J PEM mice relative to controls fed a normal-protein diet.
Reduced iNOS levels in CF epithelial cells have been independently
noted (19). Histopathological examination indicated an
increase in the neutrophil and other inflammatory cell infiltration in
the lungs of mice under PEM (Fig. 3). The
neutrophil-recruiting chemokines MIP-2 and KC, which represent
functional equivalents of human IL-8 in the mouse (16, 34,
35), were increased (50% for MIP-2 [P < 0.01]
and 60% for KC [P < 0.05]) in C57BL/6J PEM animals
relative to mice fed normal diet (Fig. 2C). There was also a 30%
increase in MPO activity in the PEM mice (P < 0.05)
(Fig. 2D).

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 2.
TNF- (A) and total nitrite (B) in the lungs of
control C57BL/6J and PEM mice 18 h following exposure to P. aeruginosa aerosols; levels of MIP-2 (C), KC (C), and MPO (D) in
the lungs of control (fed normal-protein diet) and PEM mice 18 h
following exposure to P. aeruginosa aerosols. **,
P < 0.01; *, P < 0.05 (ANOVA post
hoc t test).
|
|

View larger version (95K):
[in this window]
[in a new window]
|
FIG. 3.
Increased neutrophil and inflammatory cell infiltration
in PEM mice exposed to P. aeruginosa. (A) Control C57BL/6J
mice fed normal-protein diet; (B) malnourished mice (PEM) fed
low-protein diet. Both groups of mice were exposed as in Fig. 1.
|
|
Reduced levels of IL-10 in a chronically infected malnourished
host.
In addition to increased levels of proinflammatory cytokines
and neutrophil infiltration, another hallmark of CF is a low level of
the major anti-inflammatory cytokine IL-10 in the bronchoalveolar fluid
(5). In a model of chronic infection with P. aeruginosa that has been previously used to test effects of IL-10
on inflammatory processes due to P. aeruginosa infection
(39), the clearance of P. aeruginosa remained
less efficient in malnourished animals (Fig.
4A). We also observed production of
significant amounts of IL-10 in the well-nourished mice 22 days
following the initiation of a regimen of repeated exposure to P. aeruginosa aerosols (Fig. 4B). In contrast, the malnourished
animals had no detectable IL-10 (Fig. 4B). In normally fed mice (which
prior to infection showed less than 9.0 pg of IL-10 per g), IL-10 was
present at a level of 86.5 ± 11.9 pg/g of lung tissue. IL-10
levels were below the detection limit (9.0 pg/g) in the malnourished
animals (Fig. 4B). In the chronic infection model, PEM also resulted in
a 2.1-fold increase in MIP-2 relative to animals on the normal-protein
diet (P < 0.05; Fig. 4C) although the levels of KC
were similar in both groups of mice (P = 0.4679). MPO
levels in chronically infected PEM mice were 2.3-fold higher than in
the normally fed mice (P < 0.01; Fig. 4C).

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 4.
(A) Pulmonary clearance in chronically infected PEM
mice. Mice were repeatedly exposed (eight times, every 72 h) to
P. aeruginosa as previously described (39). (B
and C) IL-10 (B), MIP-2 (C), KC (C), and MPO (C) in chronically
infected mice. **, P < 0.01; *, P < 0.05 (ANOVA post hoc t test).
|
|
 |
DISCUSSION |
In this work, we report reduced clearance of P. aeruginosa from the respiratory tract of transgenic mice lacking
TNF-
and iNOS, suggesting that these mediators of innate immunity
may be critical for lung defenses against Pseudomonas
infection. In contrast to TNF-
and iNOS transgenic mice, IFN-
knockout mice do not show reduced P. aeruginosa clearance,
suggesting that this cytokine does not play a major role in the early
stages of Pseudomonas colonization. Any iNOS role in the
control of P. aeruginosa immediately upon aerosol delivery
is most likely independent of the IFN-
-mediated induction of iNOS in
murine phagocytic cells. The production of iNOS has been reported to be
constitutive in both human and murine airway epithelia (19),
and these cells could be the source of the effects observed in our
model system. In vitro killing of P. aeruginosa with sodium
nitroprusside (19), NO-dependent killing of P. aeruginosa in excised murine lungs (19), and reduced
control of P. aeruginosa in animals treated with the iNOS
inhibitor aminoguanidine (13) have also been reported. These
analyses along with our findings using iNOS knockout animals are
consistent with the conclusion that NO plays a role in P. aeruginosa control in the respiratory tract. Since iNOS levels and
NO output are reduced in CF epithelia (19, 27), this
deficiency may contribute to the colonization with P. aeruginosa.
The transgenic animals lacking TNF-
showed the most striking defect
in clearing P. aeruginosa in our infection model. A role for
TNF-
in the innate resistance to P. aeruginosa infection has also been proposed by others based on a correlation between TNF-
levels in BALB/c and C57BL/6 strains of mice and their differential susceptibility to endobronchial instillation of P. aeruginosa embedded in agar beads (13). Furthermore,
depletion of TNF-
increases bacterial loads in some strains of mice
(13), in keeping with our observations with transgenic
animals. Buret et al. (8) have noticed that
intratracheal administration of TNF-
in rats improves P. aeruginosa clearance from the lungs. The function of TNF-
in
resistance to P. aeruginosa colonization most likely involves a number of mechanisms, including recruitment of
neutrophils and macrophages via effects on adhesion molecules or
chemoattractants or by affecting bactericidal activities of
phagocytic cells. Our unpublished results indicate that bone
marrow-derived macrophages from TNF-
knockout mice are diminished in
the ability to kill P. aeruginosa during early time points,
suggesting that this defect could be one of the contributing factors to
the observed reduced P. aeruginosa clearance in TNF-
transgenic mice. Paradoxically, TNF-
levels are elevated in
bronchoalveolar lavage fluids in CF (5), and yet the
patients cannot clear Pseudomonas from their lungs. This
discrepancy can be best explained by the observation that the
immunoreactive TNF-
in CF bronchoalveolar fluids is biologically
inactive, as it is complexed with soluble TNF-
receptor which is
also elevated in CF lung fluids (5). The TNF-
in CF is
thus most likely not available to stimulate antipseudomonal activities
in the respiratory tract.
In this report we also examined the effects of malnutrition on
clearance and relevant cytokine profiles in the lung. A potential role
for malnutrition in CF has been considered in a follow-up to the
observation that variable body weight in
CFTRm1Unc
/
mice with intestinal dysfunction
was associated with variability in P. aeruginosa respiratory
clearance. While we could not establish a statistically significant
difference between CFTRm1Unc
/
and C57BL/6J
mice, the variability in P. aeruginosa clearance was
excessive in the CFTRm1Unc
/
group.
Importantly, this variability was not observed in the bitransgenic
mouse with the corrected CFTR defect in the intestinal tract. An
observation suggesting increased susceptibility to P. aeruginosa infections of CFTR knockout mice relative to
C57BL/6 mice has been reported in a model of intratracheal instillation of P. aeruginosa entrapped in agar beads with animal
mortality as an outcome measure (14). Although in our
studies we did not observe mortality in mice exposed to aerosolized
P. aeruginosa, indicating obvious differences between the
two models, the data shown in the study by Gosselin et al.
(14) also point to a correlation between the reduced body
weight in CFTR mice and increased bacterial burden relative
to the control experimental group. In addition, other authors using
strains of CFTR knockout mice prone to spontaneous early
onset progressive lung disease have reported severe intestinal disease
in such animals (20).
Nutritional problems in CF are complex and not limited to PEM, as they
also include essential fatty acid and subclinical micronutrient deficiencies present even in well-nourished CF subjects (32, 33). Nevertheless, protein calorie malnutrition is a critical feature of CF and a significant determinant of clinical prognosis (24). It has been strongly associated with morbidity and
mortality in young infants with CF, especially those fed soy formula
and not receiving pancreatic enzyme supplements (1). Severe
PEM is always accompanied by infection and decline in pulmonary
function in CF (18). PEM status has significant impact on
long-term prognosis in CF (24, 32). It has also been
associated with essential fatty acid deficiencies often reported in CF
patients (26), albeit some recent studies indicate that PEM
and fatty acid abnormalities can be dissociated (33).
Importantly, PEM in CF patents cannot be completely corrected despite
regular treatments with pancreatic enzyme supplements (3)
and further boosting of weight and linear growth in young patients with
CF may require additional interventions, as recently illustrated in
studies with growth hormone administration (2). PEM is
further exacerbated during growth spurts, with increased demands for
nutrient delivery often compounded by deterioration in dietary
compliance during adolescence (6). It is worth noting that
the incidence of P. aeruginosa infections in CF escalates with age, ranging from 1 to 10% in the age group from 0 to 4 years and
rising to 80% in the age group from 10 to 14 and above (11, 29). The pattern of incidence of P. aeruginosa
infections in CF, reaching a plateau between the age groups of 10 to 14 and 15 to 19 years, is often attributed to antibiotic treatment of infections caused by other pathogens (which conversely to P. aeruginosa decline in incidence with age), but additional or
alternative explanations, potentially including effects of
malnutrition, should not be excluded.
The results presented in this work indicate that malnutrition can
compromise pulmonary defenses against P. aeruginosa
colonization and is conducive to excessive inflammation in response to
P. aeruginosa infection, resembling the situation in CF. PEM
animals showed significantly reduced production of TNF-
and NO in
response to P. aeruginosa challenge relative to the
well-nourished experimental group. Importantly, neutrophil infiltration
in the lungs of malnourished animals did not result in increased
bacterial clearance from the lung and instead was a correlate of
unproductive inflammatory response. PEM also prevented production of
IL-10 during chronic infection with P. aeruginosa, the
critical anti-inflammatory cytokine that is lacking in the
bronchoalveolar fluids in CF (5) and is necessary to control
excessive inflammation in the murine lung chronically infected with
P. aeruginosa (39).
In conclusion, we propose the following model: (i) defective
CFTR in CF causes dysfunction of the digestive system, and
(ii) the ensuing malnutrition adversely affects innate lung defenses contributing to bacterial colonization and associated inflammation in
addition to other direct effects of CFTR in the lung (4, 5, 12,
22, 31, 36, 40). A prediction from the relationships uncovered in
this work is that the function of CFTR in the intestinal tract may be as critical for lung defenses against P. aeruginosa, as its direct roles may be at the level of the
respiratory epithelium (4, 5, 12, 22, 31, 36, 40). We
propose that in order to improve the compromised innate immunity in the
CF lung, future treatment efforts, including gene therapy and other
means of correcting the CFTR defect, should consider potential benefits of similar interventions in the intestinal tract.
 |
ACKNOWLEDGMENTS |
This work was supported by grants AI31139 from National
Institutes of Health and 96PO from Cystic Fibrosis Foundation and in
part by a grant from the University of Michigan.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, University of Michigan Medical School,
5641 Medical Science Building II, Ann Arbor, MI 48109-0620. Phone: (734) 763-1580. Fax: (734) 647-6243. E-mail:
Deretic{at}umich.edu.
Editor:
E. I. Tuomanen
 |
REFERENCES |
| 1.
|
Abman, S. H.,
F. J. Accurso, and C. M. Bowman.
1986.
Persistent morbidity and mortality of protein calorie malnutrition in young infants with cystic fibrosis.
J. Pediatr. Gastroenterol. Nutr.
5:393-396[Medline].
|
| 2.
|
Alemzadeh, R.,
L. Upchurch, and V. McCarthy.
1998.
Anabolic effects of growth hormone treatment in young children with cystic fibrosis.
J. Am. Coll. Nutr.
17:419-424[Abstract/Free Full Text].
|
| 3.
|
Benabdeslam, H.,
I. Garcia,
G. Bellon,
R. Gilly, and A. Revol.
1998.
Biochemical assessment of the nutritional status of cystic fibrosis patients with pancreatic enzyme extracts.
Am. J. Clin. Nutr.
67:817-818[Medline].
|
| 4.
|
Biwersi, J., and A. S. Verkman.
1994.
Functions of CFTR other than as a plasma membrane chloride channel, p. 155-171.
In
J. A. Dodge, D. J. H. Brock, and J. H. Widdicombe (ed.), Cystic fibrosis-current topics, vol. 2. John Wiley & Sons Ltd., Chichester, England.
|
| 5.
|
Bonfield, T. L.,
J. R. Panuska,
M. W. Konstan,
K. A. Hillard,
J. B. Hillard,
H. Ghnaim, and M. Berger.
1995.
Inflammatory cytokines in cystic fibrosis lungs.
Am. J. Respir. Crit. Care Med.
152:2111-2118[Abstract].
|
| 6.
|
Booth, I. W.
1991.
The nutritional consequences of gastrointestinal disease in adolescence.
Acta Paediatr. Scand. Suppl.
373:91-102[Medline].
|
| 7.
|
Borowitz, D.
1994.
Pathophysiology of gastrointestinal complications of cystic fibrosis.
Semin. Respir. Crit. Care Med.
15:391-401[CrossRef].
|
| 8.
|
Buret, A.,
M. L. Dunkley,
G. Pang,
R. L. Clancy, and A. W. Cripps.
1994.
Pulmonary immunity to Pseudomonas aeruginosa in intestinally immunized rats roles of alveolar macrophages, tumor necrosis factor alpha, and interleukin-1 alpha.
Infect. Immun.
62:5335-5343[Abstract/Free Full Text].
|
| 9.
|
Chan, J.,
Y. Tian,
K. E. Tanaka,
M. S. Tsang,
K. Yu,
P. Salgame,
D. Carroll,
Y. Kress,
R. Teitelbaum, and B. R. Bloom.
1996.
Effects of protein calorie malnutrition on tuberculosis in mice.
Proc. Natl. Acad. Sci. USA
93:14857-14861[Abstract/Free Full Text].
|
| 10.
|
Collins, F. S.
1992.
Cystic fibrosis: molecular biology and therapeutic implications.
Science
256:774-779[Abstract/Free Full Text].
|
| 11.
|
FitzSimmons, S. C.
1993.
The changing epidemiology of cystic fibrosis.
J. Pediatr.
122:1-9[Medline].
|
| 12.
|
Goldman, M. J.,
G. M. Anderson,
E. D. Stolzenberg,
U. P. Kari,
M. Zasloff, and J. M. Wilson.
1997.
Human -defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis.
Cell
88:553-560[CrossRef][Medline].
|
| 13.
|
Gosselin, D.,
J. DeSanctis,
M. Boule,
E. Skamene,
C. Matouk, and D. Radzioch.
1995.
Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa.
Infect. Immun.
63:3272-3278[Abstract].
|
| 14.
|
Gosselin, D.,
M. M. Stevenson,
E. A. Cowley,
U. Griesenbach,
D. H. Eidelman,
M. Boule,
M. F. Tam,
G. Kent,
E. Skamene,
L. C. Tsui, and D. Radzioch.
1998.
Impaired ability of Cftr knockout mice to control lung infection with Pseudomonas aeruginosa.
Am. J. Respir. Crit. Care Med.
157:1253-1262[Abstract/Free Full Text].
|
| 15.
|
Govan, J. R. W., and V. Deretic.
1996.
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.
Microbiol. Rev.
60:539-574[Abstract/Free Full Text].
|
| 16.
|
Greenberger, M. J.,
R. M. Strieter,
S. L. Kunkel,
J. M. Danforth,
L. L. Laichalk,
D. C. McGillicuddy, and T. J. Standiford.
1996.
Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumoniae.
J. Infect. Dis.
173:159-165[Medline].
|
| 17.
|
Hobden, J. A.,
S. A. Masinick,
R. P. Barrett, and L. D. Hazlett.
1997.
Proinflammatory cytokine deficiency and pathogenesis of Pseudomonas aeruginosa keratitis in aged mice.
Infect. Immun.
65:2754-2758[Abstract].
|
| 18.
|
Holt, T. L.,
L. C. Ward,
P. J. Francis,
A. Isles,
W. G. Cooksley, and R. W. Shepherd.
1985.
Whole body protein turnover in malnourished cystic fibrosis patients and its relationship to pulmonary disease.
Am. J. Clin. Nutr.
41:1061-1066[Abstract/Free Full Text].
|
| 19.
|
Kelley, T. J., and M. L. Drumm.
1998.
Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells.
J. Clin. Investig.
102:1200-1207[Medline].
|
| 20.
|
Kent, G.,
R. Iles,
C. E. Bear,
L. Huan,
U. Griesenbach,
C. McKerlie,
H. Frndova,
C. Ackerley,
D. Gosselin,
D. Razioch,
H. O'Brodovich,
L. Tsui,
M. Buchwald, and A. K. Tanswell.
1997.
Lung disease in mice with cystic fibrosis.
J. Clin. Investig.
100:3060-3069[Medline].
|
| 21.
|
Kerem, E.,
B. Corey,
B.-S. Kerem, et al.
1989.
Clinical and genetic comparisons of patients with cystic fibrosis with or without meconium ileus.
J. Pediatr.
114:767-773[CrossRef][Medline].
|
| 22.
|
Khan, T. Z.,
J. S. Wagener,
T. Bost,
J. Martinez,
F. J. Accurso, and D. W. H. Riches.
1995.
Early pulmonary inflammation in infants with cystic fibrosis.
Am. J. Respir. Crit. Care Med.
151:1075-1082[Abstract].
|
| 23.
|
Konstan, M. W., and M. Berger.
1993.
Infection and inflammation of the lung in cystic fibrosis, p. 219-276.
In
P. B. Davis (ed.), Cystic fibrosis, vol. 64. Marcel Dekker, Inc., New York, N.Y.
|
| 24.
|
Kraemer, R.,
A. Rudeberg,
B. Hadorn, and E. Rossi.
1978.
Relative underweight in cystic fibrosis and its prognostic value.
Acta Paediatr. Scand.
67:33-37[Medline].
|
| 25.
|
Lai, H. C.,
M. R. Kosorok,
S. A. Sondel,
S. T. Chen,
S. C. FitzSimmons,
C. G. Green,
G. Shen,
S. Walker, and P. M. Farrell.
1998.
Growth status in children with cystic fibrosis based on the national cystic fibrosis patient registry data: evaluation of various criteria used to identify malnutrition.
J. Pediatr.
132:478-485[CrossRef][Medline].
|
| 26.
|
Landon, C.,
J. A. Kerner,
R. Castillo,
L. Adams,
R. Whalen, and N. J. Lewiston.
1981.
Oral correction of essential fatty acid deficiency in cystic fibrosis.
JPEN J. Parenter. Enteral Nutr.
5:501-504[Abstract/Free Full Text].
|
| 27.
|
Meng, Q. H.,
D. R. Springall,
A. E. Bishop,
K. Morgan,
T. J. Evans,
S. Habib,
D. C. Gruenert,
K. M. Gyi,
M. E. Hodson,
M. H. Yacoub, and J. M. Polak.
1998.
Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis.
J. Pathol.
184:323-331[CrossRef][Medline].
|
| 28.
|
Mornet, E.,
J. L. Serre, and M. E. A. Farrall.
1988.
Genetic differences between cystic fibrosis with and without meconium ileus.
Lancet
i:376-378.
|
| 29.
|
Pedersen, S. S.,
T. Jensen,
T. Pressler,
N. Hoiby, and K. Rosendal.
1986.
Does centralized treatment of cystic fibrosis increase the risk of Pseudomonas aeruginosa infection?
Acta Paediatr. Scand.
75:840-845[Medline].
|
| 30.
|
Pencharz, P., and P. Durie.
1993.
Nutritional management of cystic fibrosis.
Annu. Rev. Nutr.
13:111-136[CrossRef][Medline].
|
| 31.
|
Pier, G. B.,
M. Grout,
T. S. Zaidi,
J. C. Olsen,
L. G. Johnson,
J. R. Yankaska, and J. B. Goldberg.
1996.
Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections.
Science
271:64-67[Abstract].
|
| 32.
|
Roulet, M.
1994.
Protein-energy malnutrition in cystic fibrosis patients.
Acta Pediatr. Suppl.
395:43-48.
|
| 33.
|
Roulet, M.,
P. Frascarolo,
I. Rappaz, and M. Pilet.
1997.
Essential fatty acid deficiency in well nourished young cystic fibrosis patients.
Eur. J. Pediatr.
156:952-956[CrossRef][Medline].
|
| 34.
|
Schall, T. J.
1994.
The chemokines, p. 419-460.
In
A. W. Thomson (ed.), The cytokine handbook, 2nd ed. Academic Press, San Diego, Calif.
|
| 35.
|
Schmal, H.,
T. P. Shanley,
M. L. Jones,
H. P. Friedl, and P. A. Ward.
1996.
Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats.
J. Immunol.
156:1963-1972[Abstract].
|
| 36.
|
Smith, J. J.,
S. M. Travis,
E. P. Greenberg, and M. J. Welsh.
1996.
Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid.
Cell
85:1-20[CrossRef][Medline].
|
| 37.
|
Snouwaert, J. N.,
K. K. Brigman,
A. M. Latour,
N. N. Malouf,
R. C. Boucher,
O. Smithies, and B. H. Koller.
1992.
An animal model for cystic fibrosis made by gene targeting.
Science
257:1083-1088[Abstract/Free Full Text].
|
| 38.
|
van Buren, C. T.,
F. B. Rudolph,
A. Kulkarni,
R. Pizzini,
W. C. Fanslow, and S. Kumar.
1990.
Reversal of immunosuppression induced by a protein-free diet: comparison of nucleotides, fish oil, and arginine.
Crit. Care Med.
18:S114-S117[CrossRef][Medline].
|
| 39.
|
Yu, H.,
M. Hanes,
C. E. Chrisp,
J. C. Boucher, and V. Deretic.
1998.
Microbial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated repiratory challenge.
Infect. Immun.
66:280-288[Abstract/Free Full Text].
|
| 40.
|
Zar, H.,
L. Saiman,
L. Quittell, and A. Prince.
1995.
Binding of Pseudomonas aeruginosa to respiratory epithelial cells from patients with various mutations in the cystic fibrosis transmembrane regulator.
J. Pediatr.
126:230-233[CrossRef][Medline].
|
| 41.
|
Zhou, L.,
C. R. Dey,
S. E. Wert,
M. D. DuVall,
R. A. Frizzell, and J. A. Whitsett.
1994.
Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR.
Science
266:1705-1708[Abstract/Free Full Text].
|
Infection and Immunity, April 2000, p. 2142-2147, Vol. 68, No. 4
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Kukavica-Ibrulj, I, Levesque, R C
(2008). Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies. Lab Anim
42: 389-412
[Abstract]
[Full Text]
-
Poschet, J. F., Timmins, G. S., Taylor-Cousar, J. L., Ornatowski, W., Fazio, J., Perkett, E., Wilson, K. R., Yu, H. D., de Jonge, H. R., Deretic, V.
(2007). Pharmacological modulation of cGMP levels by phosphodiesterase 5 inhibitors as a therapeutic strategy for treatment of respiratory pathology in cystic fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol.
293: L712-L719
[Abstract]
[Full Text]
-
Wilson, K. R., Napper, J. M., Denvir, J., Sollars, V. E., Yu, H. D.
(2007). Defect in early lung defence against Pseudomonas aeruginosa in DBA/2 mice is associated with acute inflammatory lung injury and reduced bactericidal activity in naive macrophages. Microbiology
153: 968-979
[Abstract]
[Full Text]
-
Guilbault, C., Saeed, Z., Downey, G. P., Radzioch, D.
(2007). Cystic Fibrosis Mouse Models. Am. J. Respir. Cell Mol. Bio.
36: 1-7
[Abstract]
[Full Text]
-
Moeller, A, Horak, F Jr, Lane, C, Knight, D, Kicic, A, Brennan, S, Franklin, P, Terpolilli, J, Wildhaber, J H, Stick, S M
(2006). Inducible NO synthase expression is low in airway epithelium from young children with cystic fibrosis. Thorax
61: 514-520
[Abstract]
[Full Text]
-
Yarden, J, Radojkovic, D, De Boeck, K, Macek, M Jr, Zemkova, D, Vavrova, V, Vlietinck, R, Cassiman, J-J, Cuppens, H
(2005). Association of tumour necrosis factor alpha variants with the CF pulmonary phenotype. Thorax
60: 320-325
[Abstract]
[Full Text]
-
Werner, A., Bongers, M. E. J., Bijvelds, M. J., de Jonge, H. R., Verkade, H. J.
(2004). No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis. J. Lipid Res.
45: 2277-2286
[Abstract]
[Full Text]
-
Norkina, O., Kaur, S., Ziemer, D., De Lisle, R. C.
(2004). Inflammation of the cystic fibrosis mouse small intestine. Am. J. Physiol. Gastrointest. Liver Physiol.
286: G1032-G1041
[Abstract]
[Full Text]
-
Mueller-Ortiz, S. L., Drouin, S. M., Wetsel, R. A.
(2004). The Alternative Activation Pathway and Complement Component C3 Are Critical for a Protective Immune Response against Pseudomonas aeruginosa in a Murine Model of Pneumonia. Infect. Immun.
72: 2899-2906
[Abstract]
[Full Text]
-
van Heeckeren, A. M., Scaria, A., Schluchter, M. D., Ferkol, T. W., Wadsworth, S., Davis, P. B.
(2004). Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection. Am. J. Physiol. Lung Cell. Mol. Physiol.
286: L717-L726
[Abstract]
[Full Text]
-
van Heeckeren, A. M., Schluchter, M., Xue, L., Alvarez, J., Freedman, S., St. George, J., Davis, P. B.
(2004). Nutritional Effects on Host Response to Lung Infections with Mucoid Pseudomonas aeruginosa in Mice. Infect. Immun.
72: 1479-1486
[Abstract]
[Full Text]
-
Carpagnano, G. E., Barnes, P. J., Geddes, D. M., Hodson, M. E., Kharitonov, S. A.
(2003). Increased Leukotriene B4 and Interleukin-6 in Exhaled Breath Condensate in Cystic Fibrosis. Am. J. Respir. Crit. Care Med.
167: 1109-1112
[Abstract]
[Full Text]
-
Arkwright, P. D., Pravica, V., Geraghty, P. J., Super, M., Webb, A. K., Schwarz, M., Hutchinson, I. V.
(2003). End-Organ Dysfunction in Cystic Fibrosis: Association with Angiotensin I Converting Enzyme and Cytokine Gene Polymorphisms. Am. J. Respir. Crit. Care Med.
167: 384-389
[Abstract]
[Full Text]
-
Steinkamp, G, Wiedemann, B
(2002). Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project. Thorax
57: 596-601
[Abstract]
[Full Text]
-
Hart, C A., Winstanley, C.
(2002). Persistent and aggressive bacteria in the lungs of cystic fibrosis children. Br Med Bull
61: 81-96
[Abstract]
[Full Text]
-
Poschet, J. F., Boucher, J. C., Tatterson, L., Skidmore, J., Van Dyke, R. W., Deretic, V.
(2001). Molecular basis for defective glycosylation and Pseudomonas pathogenesis in cystic fibrosis lung. Proc. Natl. Acad. Sci. USA
98: 13972-13977
[Abstract]
[Full Text]
-
KHARITONOV, S. A., BARNES, P. J.
(2001). Exhaled Markers of Pulmonary Disease. Am. J. Respir. Crit. Care Med.
163: 1693-1722
[Full Text]